logo

Eyegate Pharmaceuticals Inc (EYEG)



Trade EYEG now with
  Date
  Headline
10/2/2018 6:56:18 AM EyeGate Pharma Signs Technology Transfer And License Agreement With SentrX Animal Care
9/25/2018 6:56:12 AM EyeGate Says Granted Additional 180 Days To Comply With Nasdaq’s Continued Listing Rules
9/24/2018 6:59:32 AM EyeGate Pharmaceuticals Completes Enrollment In Both PRK And PE Pilot Studies
9/4/2018 8:34:04 AM EyeGate Announces Top-Line Results For Phase 3 Trial Of EGP-437 In Anterior Uveitis
8/20/2018 8:34:54 AM EyeGate Announces Enrollment Of First Patient In PRK Pilot Study
8/3/2018 8:33:03 AM EyeGate Pharma Q2 Net Loss $2.780 Mln Vs Loss $3.327 Mln Last Year
7/24/2018 8:32:48 AM EyeGate Announces FDA Approval Of Two IDE Submissions For Ocular Bandage Gel
6/22/2018 8:31:41 AM EyeGate Addresses Final Action Item In FDA Review Of Investigational Device Exemption For Second Pilot Study Of OBG
5/30/2018 8:36:17 AM EyeGate Files Investigational Device Exemption Supplement For Punctate Epitheliopathy
5/22/2018 8:41:49 AM EyeGate Addresses 3 Of 4 Outstanding Items In Second Amendment In Response To FDA Review Of First Amendment
4/13/2018 7:01:41 AM EyeGate Prices Public Offering Of Common Shares And Warrants
4/9/2018 8:31:15 AM EyeGate Gets FDA Feedback On Investigational Device Exemption Amendment For Second Pilot Study Of Ocular Bandage Gel
4/6/2018 8:34:00 AM EyeGate Completes Enrollment And Gets Milestone Payment For Confirmatory Phase 3 Clinical Study Of EGP-437
3/8/2018 8:33:54 AM EyeGate Submits Investigational Device Exemption Amendment For Second Pilot Study Of Ocular Bandage Gel
2/5/2018 8:35:36 AM EyeGate Reports Top-Line Results For Phase 2b Trial Of EGP-437 In Cataract Surgery
1/4/2018 8:33:41 AM EyeGate Pharmaceuticals Says Promotes Sarah Romano To CFO, Effective Jan. 1